{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:05:07Z","timestamp":1790960707885,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T00:00:00Z","timestamp":1489708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ijcard.2017.03.050","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T09:31:34Z","timestamp":1489483894000},"page":"22-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Cardiorenal disease connection during post-menopause: The protective role of estrogen in uremic toxins induced microvascular dysfunction"],"prefix":"10.1016","volume":"238","author":[{"given":"Jiayi","family":"Pei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Harakalova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester","family":"den Ruijter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Pasterkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk J.","family":"Duncker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne C.","family":"Verhaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Folkert W.","family":"Asselbergs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2017.03.050_bb0005","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/eurjhf\/hfq121","article-title":"Epidemiology and clinical course of heart failure with preserved ejection fraction","volume":"13","author":"Lam","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0010","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00392-011-0305-4","article-title":"Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction","volume":"100","author":"Edelmann","year":"2011","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1525-139X.2011.01011.x","article-title":"Diastolic heart failure in dialysis patients: mechanisms, diagnostic approach, and treatment","volume":"25","author":"Pecoits-Filho","year":"2012","journal-title":"Semin. Dial."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/CIRCRESAHA.115.302922","article-title":"Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies","volume":"115","author":"Sharma","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ejhf.445","article-title":"Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction","volume":"18","author":"Unger","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0030","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/eurheartj\/eht066","article-title":"Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND","volume":"34","author":"Brouwers","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0035","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ejhf.497","article-title":"Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation","volume":"18","author":"Ter Maaten","year":"2016","journal-title":"Eur. J. Heart Fail."},{"issue":"3","key":"10.1016\/j.ijcard.2017.03.050_bb0040","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCOUTCOMES.113.000221","article-title":"Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction","volume":"6","author":"Smith","year":"2013","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.ijcard.2017.03.050_bb0045","first-page":"291","article-title":"Endothelial dysfunction and cardiovascular disease","volume":"2014","author":"Widmer","year":"2014","journal-title":"Glob. Cardiol. Sci. Pract."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0050","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0055","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000350397","article-title":"Cardiorenal syndrome type 4: a review","volume":"3","author":"Clementi","year":"2013","journal-title":"Cardiorenal Med."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0060","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ejim.2009.03.006","article-title":"Evaluation of proteinuria and GFR to diagnose and classify kidney disease: systematic review and proof of concept","volume":"20","author":"Regeniter","year":"2009","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0065","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/hr.2010.113","article-title":"Metabolomic profiling of uremic solutes in CKD patients","volume":"33","author":"Toyohara","year":"2010","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0070","doi-asserted-by":"crossref","first-page":"23389","DOI":"10.1038\/srep23389","article-title":"Improved dialytic removal of protein-bound uraemic toxins with use of albumin binding competitors: an in vitro human whole blood study","volume":"6","author":"Tao","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0075","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1681\/ASN.2007121377","article-title":"A bench to bedside view of uremic toxins","volume":"19","author":"Vanholder","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0080","doi-asserted-by":"crossref","DOI":"10.1046\/j.1462-5822.2001.00145.x","article-title":"Disturbance of endothelial barrier function by bacterial toxins and atherogenic mediators a role for RhoRho kinase","author":"Aepfelbacher","year":"2001","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0085","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1525-139X.2011.00925.x","article-title":"Vascular incompetence in dialysis patients\u2013protein-bound uremic toxins and endothelial dysfunction","volume":"24","author":"Jourde-Chiche","year":"2011","journal-title":"Semin. Dial."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0090","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCHEARTFAILURE.112.972828","article-title":"Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction","volume":"6","author":"Ho","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0095","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s12170-011-0184-2","article-title":"Heart failure with preserved ejection fraction: persistent diagnosis, therapeutic enigma","volume":"5","author":"Bhuiyan","year":"2011","journal-title":"Curr. Cardiovasc. Risk. Rep."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/CIRCRESAHA.115.302929","article-title":"Heart failure with preserved ejection fraction: molecular pathways of the aging myocardium","volume":"115","author":"Loffredo","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0105","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s40266-013-0105-9","article-title":"Medication management of chronic heart failure in older adults","volume":"30","author":"Alagiakrishnan","year":"2013","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ijcard.2017.03.050_bb0110","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/HCO.0b013e32834b7faf","article-title":"Why are women more likely than men to develop heart failure with preserved ejection fraction?","volume":"26","author":"Scantlebury","year":"2011","journal-title":"Curr. Opin. Cardiol."},{"issue":"18","key":"10.1016\/j.ijcard.2017.03.050_bb0115","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s12471-010-0841-y","article-title":"Gender differences in coronary heart disease","volume":"18","author":"Maas","year":"2010","journal-title":"Neth. Hear. J."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0120","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11897-013-0155-7","article-title":"The emerging epidemic of heart failure with preserved ejection fraction","volume":"10","author":"Oktay","year":"2013","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0125","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/GME.0000000000000251","article-title":"Is early menopause a risk factor for heart failure?","volume":"21","author":"Gorodeski","year":"2014","journal-title":"Menopause"},{"key":"10.1016\/j.ijcard.2017.03.050_bb0130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archinte.1991.00400010095012","article-title":"Decreased mortality in users of estrogen replacement therapy","volume":"151","author":"Henderson","year":"1991","journal-title":"Arch. Intern. Med."},{"issue":"6","key":"10.1016\/j.ijcard.2017.03.050_bb0135","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJMoa030830","article-title":"Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women","volume":"349","author":"Hodis","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.ijcard.2017.03.050_bb0140","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement Study (HERS) Research Group","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ijcard.2017.03.050_bb0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/157488712799363253","article-title":"Vascular effects of estrogenic menopausal hormone therapy","volume":"7","author":"Reslan","year":"2012","journal-title":"Rev. Recent Clin. Trials"},{"key":"10.1016\/j.ijcard.2017.03.050_bb0150","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/13697130902929567","article-title":"The effects of hormone replacement therapy on myocardial performance in early postmenopausal women","volume":"13","author":"Duzenli","year":"2010","journal-title":"Climacteric"},{"key":"10.1016\/j.ijcard.2017.03.050_bb0155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.tox.2012.07.004","article-title":"Uremic toxin p-cresol induces disassembly of gap junctions of cardiomyocytes","volume":"302","author":"Peng","year":"2012","journal-title":"Toxicology"},{"key":"10.1016\/j.ijcard.2017.03.050_bb0160","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000349972","article-title":"Cardiorenal syndrome type 4: insights on clinical presentation and pathophysiology from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI)","volume":"182","author":"Tumlin","year":"2013","journal-title":"Contrib. Nephrol."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0165","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000327131","article-title":"Does uremia cause vascular dysfunction?","volume":"34","author":"Brunet","year":"2011","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018438","article-title":"Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations","volume":"6","author":"Mutsaers","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2017.03.050_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071199","article-title":"Optimized metabolomic approach to identify uremic solutes in plasma of stage 3-4 chronic kidney disease patients","volume":"8","author":"Mutsaers","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2017.03.050_bb0180","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.3390\/toxins7103933","article-title":"Exploring protein binding of uremic toxins in patients with different stages of chronic kidney disease and during hemodialysis","volume":"7","author":"Deltombe","year":"2015","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.ijcard.2017.03.050_bb0185","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3389\/fimmu.2015.00340","article-title":"Cellular and molecular mechanisms of chronic kidney disease with diabetes mellitus and cardiovascular diseases as its comorbidities","volume":"6","author":"Gajjala","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0190","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3390\/toxins6020665","article-title":"Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients","volume":"6","author":"Ito","year":"2014","journal-title":"Toxins (Basel)"},{"issue":"3","key":"10.1016\/j.ijcard.2017.03.050_bb0195","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1113\/EP085148","article-title":"The molecular actions of estrogen in the regulation of vascular health","volume":"101","author":"Usselman","year":"2016","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0200","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1161\/CIRCRESAHA.115.305376","article-title":"The expanding complexity of estrogen receptor signaling in the cardiovascular system","volume":"118","author":"Menazza","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0205","doi-asserted-by":"crossref","first-page":"10805","DOI":"10.1074\/jbc.M115.697334","article-title":"Estrogen enhances linkage in the vascular endothelial calmodulin network via a feedforward mechanism at the G protein-coupled estrogen receptor 1","volume":"291","author":"Tran","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0210","article-title":"Endoethelial progenitor cells are affected by Meidcations and estrogen","volume":"17","author":"Blum","year":"2015","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0215","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/CIRCRESAHA.110.216846","article-title":"Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification","volume":"107","author":"Osako","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0220","article-title":"Prevalence of chronic kidney diseases and its determinants among perimenopausal women in a rural area of North India: a community-based study","author":"Salve","year":"2012","journal-title":"Indian J. Nephrol."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0225","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/ijcp.12597","article-title":"Hormone replacement therapy, renal function and heart ultrasonographic parameters in postmenopausal women: an observational study","volume":"69","author":"Vitolo","year":"2015","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0230","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0235","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1189\/jlb.0904554","article-title":"Active participation of endothelial cells in inflammation","volume":"77","author":"Cook-Mills","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0240","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.4049\/jimmunol.1000193","article-title":"Endothelial ICAM-1 protein induction is regulated by cytosolic phospholipase A2alpha via both NF-kappaB and CREB transcription factors","volume":"186","author":"Hadad","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0245","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nrneph.2011.219","article-title":"Restoring the renal microvasculature to treat chronic kidney disease","volume":"8","author":"Long","year":"2012","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0250","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/cvr\/cvm085","article-title":"Protein kinase C alpha promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factor","volume":"78","author":"Xu","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0255","article-title":"Neuregulin activation of ErbB receptors in vascular endothelium leads to angiogenesis","author":"RUSSELL","year":"1999","journal-title":"Am. Physiol. Soc."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0260","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.3390\/cancers4041252","article-title":"Emerging roles of ADAMTSs in angiogenesis and cancer","volume":"4","author":"Kumar","year":"2012","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijcard.2017.03.050_bb0265","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive oxygen species in inflammation and tissue injury","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0270","doi-asserted-by":"crossref","DOI":"10.1080\/10739680590896072","article-title":"Potassium channels in the peripheral microcirculation","author":"JACKSON","year":"2005","journal-title":"Microcirculation"},{"key":"10.1016\/j.ijcard.2017.03.050_bb0275","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bcp.2009.04.029","article-title":"Inflammatory cytokines in vascular dysfunction and vascular disease","volume":"78","author":"Sprague","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0280","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s11897-014-0219-3","article-title":"New insights in (inter)cellular mechanisms by heart failure with preserved ejection fraction","volume":"11","author":"Tschope","year":"2014","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0285","doi-asserted-by":"crossref","first-page":"30485","DOI":"10.1074\/jbc.M701081200","article-title":"Nerve growth factor induces endothelial cell invasion and cord formation by promoting matrix metalloproteinase-2 expression through the phosphatidylinositol 3-kinase\/Akt signaling pathway and AP-2 transcription factor","volume":"282","author":"Park","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0290","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1128\/CDLI.10.3.495-497.2003","article-title":"Activation of coagulation by administration of recombinant factor VIIa elicits interleukin 6 (IL-6) and IL-8 release in healthy human subjects","volume":"10","author":"de Jonge","year":"2003","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0295","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.275.3.1521","article-title":"The hemostatic system as a regulator of angiogenesis","volume":"275","author":"Browder","year":"2000","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0300","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12192-008-0059-8","article-title":"Wound healing from a cellular stress response perspective","volume":"13","author":"Doshi","year":"2008","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.ijcard.2017.03.050_bb0305","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cardiores.2005.12.004","article-title":"Controversies regarding hormone therapy: insights from inflammation and hemostasis","volume":"70","author":"Koh","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0310","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/0192623310389474","article-title":"Current understanding of hemostasis","volume":"39","author":"Gale","year":"2011","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0315","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.thromres.2005.03.032","article-title":"Uremic bleeding: pathophysiology and clinical risk factors","volume":"118","author":"Sohal","year":"2006","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0320","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/ncpneph0421","article-title":"Evidence-based treatment recommendations for uremic bleeding","volume":"3","author":"Hedges","year":"2007","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0325","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ki.1997.317","article-title":"Renal and systemic nitric oxide synthesis in rats with renal mass reduction","volume":"52","author":"Aiello","year":"1997","journal-title":"Kidney Int."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0330","doi-asserted-by":"crossref","DOI":"10.1097\/00005344-199508000-00022","article-title":"Effect of nitric oxide synthase inhibition on bleeding time in humans","volume":"26","author":"Simon","year":"1995","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0335","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V94.8.2569.420k13_2569_2574","article-title":"Uremic bleeding closing the circle after 30years of controversies","volume":"94","author":"Noris","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.ijcard.2017.03.050_bb0340","article-title":"L-arginine, the precursor of nitric oxide, abolishes the effect of estrogens on bleeding time in experimental uremia","author":"Zoja","year":"1991","journal-title":"Lab. Investig."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0345","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1161\/CIRCRESAHA.108.174318","article-title":"Notch signaling in cardiac development","volume":"102","author":"Niessen","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0350","first-page":"19","article-title":"Low gradient \u201csevere\u201d aortic stenosis with preserved left ventricular ejection fraction","volume":"2","author":"Ozkan","year":"2012","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0355","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1161\/CIRCULATIONAHA.104.486738","article-title":"Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies","volume":"111","author":"Freeman","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.03.050_bb0360","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cardfail.2015.07.012","article-title":"Increased serum levels of the notch ligand DLL1 are associated with diastolic dysfunction, reduced exercise capacity, and adverse outcome in chronic heart failure","volume":"22","author":"Norum","year":"2016","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0365","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/cvr\/cvu021","article-title":"Signalling between microvascular endothelium and cardiomyocytes through neuregulin","volume":"102","author":"Parodi","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2017.03.050_bb0370","doi-asserted-by":"crossref","first-page":"H559","DOI":"10.1152\/ajpheart.00758.2015","article-title":"Endothelial fibroblast growth factor receptor signaling is required for vascular remodeling following cardiac ischemia-reperfusion injury","volume":"310","author":"House","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317316091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317316091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T20:53:31Z","timestamp":1601758411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527317316091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":74,"alternative-id":["S0167527317316091"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.03.050","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiorenal disease connection during post-menopause: The protective role of estrogen in uremic toxins induced microvascular dysfunction","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.03.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}